Graft-versus-host disease (GvHD) is the opposite of graft rejection in
that a transplant containing donor lymphocytes attacks the host's ski
n, liver and gut, This disease can usefully also attack host tumor cel
ls, There is a peculiar distribution of normal tissue targets in epith
elial stem cell sites, suggesting that GVHD may be the abnormal counte
rpart of a physiological growth control system, Efforts to understand
how the graft-versus-tumor effect could be therapeutically separated f
rom GvHD require further understanding of the mechanisms involved in G
vHD.